Silicon Valley billionaires are obsessed with 'reprogramming' their bodies for longevity. The first human trial suggests they may be onto something.

The first humans are trying out cellular reprogramming for longevity. It looks like it might be working.
Business Insider

The first-ever reverse-aging drug was just injected into a human

A first-of-its-kind shot that promises to reverse aging was just injected into a human body. It's a pivotal moment for longevity science, the first opportunity for researchers to prove that epigenetic ...
BIOENGINEER

Blood Cells From 80-Year-Olds Rejuvenated Into Brain Cells With Molecular Age Under 20

University of Bonn researchers directly reprogrammed red blood cell precursors from elderly donors into neural stem cells ...
GEN

Scientists Able to Reprogram Human Embryos Using Human Eggs but Not Animal Eggs

Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
Pulse 2.0

NewLimit Raises $435 Million Series C To Bring Aging Reprogramming Medicine To Human Trials

NewLimit has announced a $435 million Series C led by Founders Fund, alongside new investors Thrive Capital, Greenoaks, and Quiet Capital, and returning investors Kleiner Perkins, Abstract, Nat ...